Oct. 21, 2015
Optos has released the California, a new model of its signature product. The company describes the new instrument as “the most advanced ultra-widefield (UWF) retinal imaging system ever developed.”
“To the widest non-contact, single-capture imaging device in ophthalmology, California adds the largest number of UWF imaging modalities, including color, autofluorescence, fluorescein angiography and indocyanine green angiography in a table-top instrument,” Optos noted in a recent news release. This newest device from Optos includes technological updates for consistent resolution and anatomical scale in the far periphery, thus facilitating cross-modality image registration.
California is designed specifically for the advanced-retinal imaging requirements of ophthalmologists and vitreoretinal specialists. It is a compact, table-top, UWF retinal imaging device providing greater imaging functionality.
Optos says California features its newest imaging modality, indocyanine green angiography (ICG), while maintaining all current color imaging modalities, autofluorescence (AF) and fluorescein angiography (FA). Optomap icg is used for imaging the choroidal vasculature, necessary for the diagnosis, treatment and management of conditions such as neovascular age-related macular degeneration (AMD) and disorders with choroidal neovascular membranes.
The California has several software and hardware enhancements, including:
• OptosAdvance software that facilitates multimodality review and annotation
• Cloud-based archiving
• Platform independent review and referral management
• ProView, which enhances image registration for tracking retinal disease development over time and comparison of images across all retinal image modalities.
For more information, contact: http://www.optos.com; (800) 854-3039
